SCHEMBL10211328

SCHEMBL10211328

CCC[C@H]1COC(C)(C)N1C(=O)OC(C)(C)C

nearest known ligand 0.69

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SPHK1 Q9NYA1 1/20 0.54
HSD11B2 P80365 1/20 0.38
BRD4 O60885 1/20 0.37
ATM Q13315 2/20 0.37
CHRM2 P08172 1/20 0.35
CHRM1 P11229 1/20 0.35
CHRM3 P20309 1/20 0.35
HCRTR2 O43614 1/20 0.34
USP2 O75604 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
NR1H2 P55055 1/20 0.33
ALDH1A1 P00352 1/20 0.32
KMT2A Q03164 1/20 0.32
DDB1 Q16531 1/20 0.31
CRBN Q96SW2 1/20 0.31
RECQL P46063 1/20 0.31
CTSK P43235 1/20 0.31
GLA P06280 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11956427 1.00 SPHK1 (0.54) SPHK1HSD11B2BRD4ATMCHRM2
SCHEMBL16071281 0.92 SPHK1 (0.58) SPHK1HSD11B2BRD4ATMCHRM2
SCHEMBL18959562 0.91 SPHK1 (0.60) SPHK1HSD11B2BRD4ATMCHRM2
SCHEMBL17020101 0.89 SPHK1 (0.61) SPHK1HSD11B2BRD4CHRM2CHRM1
SCHEMBL18959559 0.89 SPHK1 (0.61) SPHK1HSD11B2BRD4CHRM2CHRM1
SCHEMBL16070969 0.89 SPHK1 (0.61) SPHK1HSD11B2BRD4CHRM2CHRM1
SCHEMBL9915254 0.89 SPHK1 (0.61) SPHK1HSD11B2BRD4CHRM2CHRM1
SCHEMBL1068506 0.89 SPHK1 (0.48) SPHK1HSD11B2BRD4ATMCHRM2
SCHEMBL1068504 0.89 SPHK1 (0.48) SPHK1HSD11B2BRD4ATMCHRM2
SCHEMBL15318844 0.89 SPHK1 (0.48) SPHK1HSD11B2BRD4ATMCHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8729113-B2 4,5-dihydro-oxazol-2yl derivatives HOFFMANN-LA ROCHE INC. (US) 2014-05-20 US disclosed
US-8729113-B2 4,5-dihydro-oxazol-2yl derivatives HOFFMANN-LA ROCHE INC. (US) 2014-05-20 US disclosed
US-8357712-B2 2013-01-22 US disclosed
US-8242153-B2 4,5-dihydro-oxazol-2YL derivatives HOFFMANN-LA ROCHE INC. (US) 2012-08-14 US disclosed
US-20120165294-A1 4,5-DIHYDRO-OXAZOL-2YL DERIVATIVES GALLEY GUIDO (DE) 2012-06-28 US disclosed
US-20110144333-A1 4,5-DIHYDRO-OXAZOL-2YL DERIVATIVES GALLEY GUIDO 2011-06-16 US disclosed
US-20100041686-A1 4,5-DIHYDRO-OXAZOL-2YL DERIVATIVES HOFFMANN-LA ROCHE, INC. 2010-02-18 US disclosed
US-20100029589-A1 4,5-DIHYDRO-OXAZOL-2YL DERIVATIVES HOFFMANN-LA ROCHE INC. 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110144333-A1 4,5-DIHYDRO-OXAZOL-2YL DERIVATIVES NPY5R, NPY1R, NPY4R SPHK1 2843/4885HSD11B2 474/4885BRD4 2047/4885
US-20100029589-A1 4,5-DIHYDRO-OXAZOL-2YL DERIVATIVES NPY5R, NPY1R, NPY4R SPHK1 2843/4885HSD11B2 474/4885BRD4 2047/4885
US-20100041686-A1 4,5-DIHYDRO-OXAZOL-2YL DERIVATIVES NPY5R, NPY1R, NPY4R SPHK1 2843/4885HSD11B2 474/4885BRD4 2047/4885
US-20120165294-A1 4,5-DIHYDRO-OXAZOL-2YL DERIVATIVES NPY5R, NPY1R, NPY4R SPHK1 2843/4885HSD11B2 474/4885BRD4 2047/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.